Experienced oncology nurses and APPs can help nurses newer to the field understand who is more at risk of opioid addiction, ...

Panelists discuss how the unprecedented 5-year progression-free survival benefit (60% vs 8%) demonstrated in the CROWN trial ...

Explore essential mental health support strategies for older adults with cancer, addressing grief, community resources, and ...

Adding sonrotoclax to zanubrutinib led to deep and durable response in relapsed or refractory mantle cell lymphoma, according ...

Panelists discuss that talquetamab dose modifications are guided primarily by patient symptoms and adverse effects, with ...

ICE-T Conference presenters explain what nurses and APPs should take into account as immune cell effector therapies become ...

Establishing routine early on helps proactively manage adverse effects associated with CDK4/6 inhibitors, says Kimberly ...

Panelists discuss City of Hope’s multidisciplinary approach, highlighting pharmacists providing medication guidance, social ...

Paolo Tarantino, MD, PhD, explains that the chemotherapy-related toxicities from an ADC are more likely to limit dosage for ...

Panelists discuss how talquetamab’s unique GPRC5D-related toxicities are managed proactively using International Myeloma Working Group guidelines, balancing outpatient delivery with vigilant ...